Article Details

Touchlight secures $2.4m to prove pandemic potential of synthetic DNA vector

Retrieved on: 2022-11-29 22:01:18

Tags for this article:

Click the tags to see associated articles and topics

Touchlight secures $2.4m to prove pandemic potential of synthetic DNA vector. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2022/11/29/Touchlight-secures-2.4m-to-prove-pandemic-potential-of-synthetic-DNA-vector

Excerpt

... performance of dbDNA for therapeutic monoclonal antibody production. ... produce therapeutic relevant levels of monoclonal antibodies in vivo.

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up